Tirzepatide
Tirzepatide (Mounjaro® / Zepbound®)
Tirzepatide is a once-weekly injectable medication shown to significantly enhance weight loss and improve long-term weight management in adults with obesity or chronic weight-related conditions.
Mechanism of Action
Tirzepatide is a synthetic polypeptide and a dual agonist of two incretin receptors:
- GIP (glucose-dependent insulinotropic polypeptide)
- GLP-1 (glucagon-like peptide-1)
These gut-derived hormones help regulate:
Insulin secretion to improve glycemic control
Reduction of hyperglycemia
Appetite suppression and increased satiety
Together, these actions support substantial and sustained weight loss.
Administration
Tirzepatide is administered as a once-weekly subcutaneous injection in the clinic.
Professional administration ensures safe dosing, correct injection technique, and minimizes risks such as injection-site complications.
Clients receive weekly weigh-ins using our medical-grade bioelectrical impedance analysis (BIA) scale. This provides detailed metrics, including:
- Body fat percentage
- Muscle mass
- Visceral fat levels
This allows precise monitoring of true fat loss versus muscle gain throughout treatment.